Fusion Family Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Fusion Family Wealth's BIIB Position: Q2 2021 in Review
Fusion Family Wealth sold out of Biogen (BIIB) in Q2 2021, closing a stake of 6 shares — an estimated $2K sold.
Fusion Family Wealth first reported a position in BIIB in Q4 2016 and held it in 18 quarters. The position peaked at $76K in Q3 2018. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.
- Fusion Family Wealth reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
- Fusion Family Wealth sold 6 Biogen shares in Q2 2021, an estimated $2K.
- Fusion Family Wealth first reported a position in Biogen in Q4 2016 and held it in 18 quarters.
- Fusion Family Wealth's Biogen position peaked at $76K in Q3 2018.
- 1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.
Based on Fusion Family Wealth's 13F filing for Q2 2021, filed 30 Jul 2021.